CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- Open-market buys, last 90 days
- $252,875
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-06 | Winslow Garrett General Counsel | Sale | −245 | $29.98 | $7K | 2,289 |
| 2026-01-02 | Schambye Hans T. Chief Executive Officer | Sale | −700 | $21.38 | $15K | 4,682 |
| 2026-01-02 | Winslow Garrett General Counsel | Sale | −255 | $21.38 | $5K | 1,854 |
| 2026-01-02 | Firmani Lori Chief Financial Officer | Sale | −135 | $21.41 | $3K | 931 |
| 2025-07-03 | Schambye Hans T. Chief Executive Officer | Sale | −735 | $3.38 | $2K | 4,022 |
| 2025-07-03 | Winslow Garrett General Counsel | Sale | −260 | $3.39 | $881 | 1,429 |
| 2025-07-03 | Firmani Lori Interim CFO | Sale | −147 | $3.39 | $498 | 692 |
| 2025-01-03 | Winslow Garrett General Counsel | Sale | −471 | $5.60 | $3K | 1,009 |
| 2025-01-03 | Firmani Lori Interim CFO | Sale | −261 | $5.63 | $1K | 465 |
| 2025-01-03 | Schambye Hans T. Chief Executive Officer | Sale | −1,341 | $5.60 | $8K | 3,397 |
| 2023-08-15 | ORBIMED ADVISORS LLC 10% owner | Sale | −38,327 | $0.75 | $29K | 97,204 |
| 2023-08-15 | ORBIMED ADVISORS LLC 10% owner | Sale | −248,819 | $0.75 | $187K | 631,048 |
| 2023-08-15 | ORBIMED ADVISORS LLC 10% owner | Sale | −535,534 | $0.75 | $402K | 1,510,375 |
| 2023-07-31 | ORBIMED ADVISORS LLC 10% owner | Sale | −26,622 | $3.00 | $80K | 135,531 |
| 2023-07-31 | ORBIMED ADVISORS LLC 10% owner | Sale | −29,700 | $3.00 | $89K | 879,867 |
| 2023-07-31 | ORBIMED ADVISORS LLC 10% owner | Sale | −153,078 | $3.00 | $459K | 2,105,909 |
| 2023-07-25 | ORBIMED ADVISORS LLC 10% owner | Sale | −7,800 | $2.92 | $23K | 162,153 |
| 2023-07-25 | ORBIMED ADVISORS LLC 10% owner | Sale | −4,700 | $2.92 | $14K | 909,567 |
| 2023-07-25 | ORBIMED ADVISORS LLC 10% owner | Sale | −26,700 | $2.92 | $78K | 2,258,987 |
| 2023-07-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −9,800 | $2.40 | $24K | 169,953 |
Page 1 of 3 · 46 trades